APP and Alzheimer disease: Exen decreases Aβ toxicity and oxidative stress in primary neuronal cultures and SH-SY5Y cells, interferes with the development of cognitive impairment, and significantly reduces brain levels of APP and Aβ in animal AD models [37,38,39,40].